SCHEMBL22475985

SCHEMBL22475985

Nc1ccc(-c2cnn(CCO)c2)nc1N(N)C1(c2ccc3ncccc3c2)CC1

nearest known ligand 0.46

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MET P08581 15/20 0.46
PDE3B Q13370 2/20 0.45
PDE3A Q14432 2/20 0.45
PDE10A Q9Y233 2/20 0.45
CYP2C9 P11712 1/20 0.45
PDE4C Q08493 1/20 0.43
PDE4D Q08499 1/20 0.43
FGFR1 P11362 1/20 0.39
FGFR2 P21802 1/20 0.39
FGFR4 P22455 1/20 0.39
FGFR3 P22607 1/20 0.39
KDR P35968 1/20 0.39
JAK2 O60674 3/20 0.38
JAK1 P23458 3/20 0.38
TYK2 P29597 3/20 0.38
JAK3 P52333 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21167772 0.81 MET (0.54) METPDE3BPDE3APDE10ACYP2C9
SCHEMBL24591059 0.81 MET (0.47) METPDE3BPDE3APDE10ACYP2C9
SCHEMBL21167532 0.79 MET (0.55) METPDE3BPDE3APDE10ACYP2C9
SCHEMBL21167744 0.79 MET (0.55) METPDE3BPDE3APDE10ACYP2C9
SCHEMBL12482735 0.76 MET (0.42) METPDE3BPDE3APDE10APDE4C
SCHEMBL21167471 0.75 MET (0.42) METPDE3BPDE3APDE10ACYP2C9
SCHEMBL12482436 0.75 MET (0.54) METPDE3BPDE3APDE10ACYP2C9
SCHEMBL21167616 0.73 MET (0.55) METPDE3BPDE3APDE10ACYP2C9
SCHEMBL21167794 0.73 MET (0.47) METPDE3BPDE3APDE10ACYP2C9
SCHEMBL21167613 0.72 MET (0.53) METPDE3BPDE3APDE10ACYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3511330-B1 SYNTHETIC INTERMEDIATE USEFUL IN THE PREPARATION OF TRIAZOLOPYRIDINE C-MET INHIBITORS HUTCHISON MEDIPHARMA LTD (CN) 2020-09-30 EP disclosed